help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braun, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, L.

American Journal of Pathology, Vol 144, 209-214, Copyright © 1994 by American Society for Investigative Pathology


REVIEWS

Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia

L Braun
Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912.

Although many basic questions about the relationship between HIV and HPV infection remain unresolved, epidemiological studies have consistently shown a strong association between HIV infection and the development of HPV-related squamous intraepithelial neoplasia. This work indicates that HIV infection may promote the clinical manifestation of subclinical or latent HPV infection. Recent technical advances localizing virus DNA and gene products in situ will provide new avenues for investigation, allowing us to go beyond correlations and to clarify the mechanisms of interaction between the two viruses in individual patients. With improved antiretroviral therapy and prophylaxis for HIV-associated opportunistic infection and prolonged survival of women with HIV, HPV infection and its most serious consequence, cervical cancer, are likely to assume greater significance in the clinical management of HIV-infected women throughout the world. A better understanding of the role of HIV in promoting the clinical manifestation of HPV infection will be essential to the control of this disease.


This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
D S Hughes, N Powell, and A N Fiander
Will vaccination against human papillomavirus prevent eye disease? A review of the evidence
Br. J. Ophthalmol., April 1, 2008; 92(4): 460 - 465.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. F. Xi and N. B. Kiviat
Cervical Neoplasia and Highly Active Antiretroviral Therapy
J Natl Cancer Inst, July 21, 2004; 96(14): 1051 - 1053.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
I. HEARD, J.-M. TASSIE, V. SCHMITZ, L. MANDELBROT, M. D. KAZATCHKINE, and G. ORTH
Increased Risk of Cervical Disease Among Human Immunodeficiency Virus-Infected Women With Severe Immunosuppression and High Human Papillomavirus Load
Obstet. Gynecol., September 1, 2000; 96(3): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Petter, K. Heim, M. Guger, A. Ciresa-Kö nig, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl
Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women
J. Gen. Virol., March 1, 2000; 81(3): 701 - 708.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.